Thomas Porstmann

Global Scientific Director
Novo Nordisk Health Care AG, Zurich, Switzerland
Zurich, Zurich, Switzerland

Presentation(s):

• PB0157 - In vitro thrombin generation in the presence of emicizumab sequence identical analogue (emi-SIA) and concizumab

  Sunday, June 25, 2023
  18:30 – 19:30 ET